Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 1,524 articles

Articles by Daniel Marsh

PepsiCo Nears 52-Week High Ahead of Dividend and Key Economic Data
Markets

PepsiCo Nears 52-Week High Ahead of Dividend and Key Economic Data

PepsiCo shares gained 1.29% to $169.74 Friday, closing just under its 52-week peak. The company faces retailer pressure on ingredients while preparing for its March 31 dividend payout.

PEP KO MDLZ TGT XLP
Home Depot Gains as Housing Data and Fed Outlook Shape Retailer's Path
Markets

Home Depot Gains as Housing Data and Fed Outlook Shape Retailer's Path

Home Depot stock advanced 1.5% Friday, closing at $380.72, while the broader market declined. The home improvement retailer's performance remains tied to interest rates and sluggish housing turnover, with key economic reports due next week.

HD LOW SPY DIA
SoFi Shares Plunge 7% Amid Broad Market Selloff
Markets

SoFi Shares Plunge 7% Amid Broad Market Selloff

SoFi Technologies shares dropped 7% on Friday, closing at $17.76 on heavy volume, as investors retreated from risk-sensitive assets ahead of key economic data.

SOFI XLK XLF
Morgan Stanley Tumbles 6% Amid Renewed Credit Fears, Jobs Data Looms
Markets

Morgan Stanley Tumbles 6% Amid Renewed Credit Fears, Jobs Data Looms

Morgan Stanley shares dropped over 6% Friday, leading a broad bank stock selloff fueled by renewed anxiety over private credit and a UK lender's failure. Investors now await the U.S. jobs report for February.

MS JEF GS XLF BMO
Merck's Keytruda, Welireg Data and FDA Dates Drive Stock Momentum
Analysis

Merck's Keytruda, Welireg Data and FDA Dates Drive Stock Momentum

Merck stock gained after reporting Phase 3 survival data for Keytruda in ovarian and kidney cancers. The FDA set 2026 review dates for Welireg combinations.

MRK RHHBY
Caterpillar Shares Dip Amid Inflation Fears, Key Data and CONEXPO in Focus
Markets

Caterpillar Shares Dip Amid Inflation Fears, Key Data and CONEXPO in Focus

Caterpillar stock declined Friday, closing at $742.83, as renewed inflation worries pressured the broader market. Traders are now focused on upcoming economic indicators and a key industry conference.

CAT DIA SPY USO
GE Aerospace Nears Record High Amid Persistent Supply Chain Concerns
Markets

GE Aerospace Nears Record High Amid Persistent Supply Chain Concerns

GE Aerospace shares gained 0.4% to $342.26, hovering near recent peaks, while supply chain constraints at major aerospace manufacturers continue to pose risks to jet delivery schedules.

GE RTX
Mastercard Gains as Investors Eye Jobs Data and AI's Fee Impact
Markets

Mastercard Gains as Investors Eye Jobs Data and AI's Fee Impact

Mastercard shares advanced 0.47% to $517.21, contrasting with broader market declines. Focus turns to upcoming economic data and executive commentary on AI's role in payments.

MA V SPY DIA XLK XLF
Salesforce Shares Slide Amid AI Uncertainty, Key Conference Ahead
Markets

Salesforce Shares Slide Amid AI Uncertainty, Key Conference Ahead

Salesforce shares declined 2.35% Friday, closing at $194.79 amid a broader software sector selloff. Investors are focused on AI agent adoption and enterprise spending trends ahead of a key Morgan Stanley conference appearance.

CRM ORCL NOW MS
Booking Holdings CFO to Speak as Stock Split and Dividend Dates Approach
Markets

Booking Holdings CFO to Speak as Stock Split and Dividend Dates Approach

Booking Holdings shares edged lower Friday as investors await a key CFO appearance and the record date for a major stock split and dividend payment.

BKNG EXPE TRIP MMYT
Visa Climbs to $320 as Markets Eye Inflation Data
Markets

Visa Climbs to $320 as Markets Eye Inflation Data

Visa shares advanced 1.09% to close at $320.14 on Friday, marking a fourth consecutive session of gains. The move occurred as producer price data fueled speculation the Federal Reserve may delay interest rate cuts.

V MA NVDA XLK XLF
Oracle Shares Drop 3.3% Amid Tech Retreat, AI Funding Scrutiny
Markets

Oracle Shares Drop 3.3% Amid Tech Retreat, AI Funding Scrutiny

Oracle shares declined 3.3% on Friday, closing at $145.40, amid a broader tech selloff. Investors are focusing on the company's upcoming earnings and its 2026 capital raise plans as AI cloud competition intensifies.

ORCL NVDA AMZN MSFT XLK